diazepam has been researched along with losartan in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Avdeef, A; Tam, KY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Carr, RD; Fraser-Rae, L; Hallam, C; Kaiser, FC; Palmer, GC; Wallace, AV | 1 |
| Armstrong, DL; Polan-Curtain, J; Wayner, MJ | 1 |
| Armstrong, DL; Denny, JB; Polan-Curtain, JL; Wayner, MJ | 1 |
| Bill, DJ; Dourish, CT; Grewal, SS; McLenachan, A; Shepherd, J; Stanhope, KJ | 1 |
| Chalas, A; Conway, EL | 1 |
| Costall, B; Naylor, RJ | 1 |
| Tracy, HA; Wayner, MJ | 1 |
| Corrêa, FM; Peres-Polon, VL; Tavares, RF | 1 |
| Shou, M | 1 |
| Ramanathan, M; Srinivasan, J; Suresh, B | 1 |
1 review(s) available for diazepam and losartan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for diazepam and losartan
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze.
Topics: Angiotensin II; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Biphenyl Compounds; Blood Pressure; Diazepam; Imidazoles; Losartan; Male; Rats; Rats, Sprague-Dawley; Tetrazoles | 1992 |
Angiotensin AII AT1 receptor mediates ethanol-diazepam inhibition of hippocampal LTP.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Diazepam; Dose-Response Relationship, Drug; Ethanol; Hippocampus; Imidazoles; Long-Term Potentiation; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles | 1994 |
Role of angiotensin II and AT1 receptors in hippocampal LTP.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Diazepam; Electric Stimulation; Electrophysiology; Ethanol; Hippocampus; Imidazoles; Learning; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Saralasin; Tetrazoles | 1993 |
Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Biphenyl Compounds; Diazepam; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Memory; Motor Activity; Pyridines; Rats; Rats, Sprague-Dawley; Scopolamine; Tetrazoles | 1996 |
No evidence for involvement of angiotensin II in spatial learning in water maze in rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Cholinergic Antagonists; Diazepam; GABA Modulators; Imidazoles; Injections, Intraventricular; Losartan; Maze Learning; Memory; Organophosphorus Compounds; Proline; Psychomotor Performance; Rats; Renin; Scopolamine; Tetrazoles | 1996 |
The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
Topics: Animals; Avoidance Learning; Behavior, Animal; Benzodiazepinones; Darkness; Devazepide; Diazepam; Drug Antagonism; Fenclonine; Indoles; Light; Losartan; Male; Meglumine; Mice; Organophosphorus Compounds; Proline; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Ritanserin; Serotonin Antagonists; Sulfonamides | 1997 |
Losartan blocks diazepam and ethanol effects on air righting.
Topics: Angiotensin Receptor Antagonists; Animals; Diazepam; Ethanol; Hippocampus; Kinetics; Long-Term Potentiation; Losartan; Male; Postural Balance; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reflex | 1998 |
Mechanisms involved in the water intake-related pressor response in the rat.
Topics: Animals; Antihypertensive Agents; Arteries; Blood Pressure; Brazil; Diazepam; Dose-Response Relationship, Drug; Drinking; Heart Rate; Idazoxan; Lidocaine; Losartan; Male; Mecamylamine; Models, Animal; Muscle Relaxants, Central; Prazosin; Quinine; Rats; Rats, Wistar; Sodium Chloride; Tropanes; Water | 2002 |
Kinetic analysis for multiple substrate interaction at the active site of cytochrome P450.
Topics: Benzoflavones; Binding Sites; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diazepam; Diclofenac; Enzyme Activation; Enzyme Inhibitors; Kinetics; Losartan; Models, Biological; Protein Binding; Quinidine; Recombinant Proteins | 2002 |
Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Anxiety Agents; Antihypertensive Agents; Anxiety; Blood Pressure; Diazepam; Enalapril; Exploratory Behavior; Hypertension, Renal; Losartan; Male; Rats; Rats, Wistar; Social Behavior | 2003 |